Nanjing Leads Biolabs (9887) Announces Inclusion in MSCI Global Small Cap Indexes

Bulletin Express
Nov 07

Nanjing Leads Biolabs Co., Ltd. (Stock Code: 9887) announced that its shares will be included in the MSCI Global Small Cap Indexes effective after the market close on November 24, 2025. This inclusion, compiled by Morgan Stanley Capital International, is designed to track the performance of smaller-capitalization companies in international markets.

According to the official announcement, the inclusion highlights investor recognition of Nanjing Leads Biolabs’ operating performance and potential for further development. Shareholders and potential investors are advised to exercise due care when trading the company’s shares. The board of directors reiterates that the inclusion in the MSCI Global Small Cap Indexes is a key milestone in the company’s ongoing growth and engagement with the global investment community.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10